富士莱：公司目前专注于仿制药业务，重点关注与特色原料药等相关领域

Group 1 - The company is currently focused on the generic drug business and is prioritizing the development and production of specialty raw materials, key intermediates, and CMO/CDMO services [2] - The company has provided an update regarding the progress of its Shandong project, indicating that further details will be disclosed in future regular reports and announcements [2]